Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 8241953, 8 pages
https://doi.org/10.1155/2017/8241953
Research Article

The Expression and Related Clinical Significance of SIRT3 in Non-Small-Cell Lung Cancer

1Department of Thoracic and Cardiovascular Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China
2Lung Cancer Research Center, Zhoushan Hospital, Zhoushan, China
3Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, China

Correspondence should be addressed to Hai Tian

Received 26 April 2017; Accepted 27 July 2017; Published 30 August 2017

Academic Editor: Silvia Angeletti

Copyright © 2017 Guo-Cai Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Chen, R. Zheng, P. D. Baade et al., “Cancer statistics in China, 2015,” CA: a Cancer Journal for Clinicians, vol. 66, no. 2, pp. 115–132, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. E. Miller, “Pathogenesis of lung cancer: 100 year report,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 3, pp. 216–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Reungwetwattana, S. J. Weroha, and J. R. Molina, “Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC),” Clinical Lung Cancer, vol. 13, no. 4, pp. 252–266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. T. A. Bhat, S. Kumar, A. K. Chaudhary, N. Yadav, and D. Chandra, “Restoration of mitochondria function as a target for cancer therapy,” Drug Discovery Today, vol. 20, no. 5, pp. 635–643, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. C. Haigis and L. P. Guarente, “Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction,” Genes & Development, vol. 20, no. 21, pp. 2913–2921, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. E. McDonnell, B. S. Peterson, H. M. Bomze, and M. D. Hirschey, “SIRT3 regulates progression and development of diseases of aging,” Trends in Endocrinology and Metabolism, vol. 26, no. 9, pp. 486–492, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Y. Alhazzazi, P. Kamarajan, N. Joo et al., “Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer,” Cancer, vol. 117, no. 8, pp. 1670–1678, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Y. Alhazzazi, P. Kamarajan, E. Verdin, and Y. L. Kapila, “SIRT3 and cancer: tumor promoter or suppressor?” Biochimica et Biophysica Acta, vol. 1816, no. 1, pp. 80–88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. M. Desouki, I. Doubinskaia, D. Gius, and S. A. Abdulkadir, “Decreased mitochondrial SIRT3 expression is a potential molecular biomarker associated with poor outcome in breast cancer,” Human Pathology, vol. 45, no. 5, pp. 1071–1077, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Takahashi, T. Sawada, T. Akahane et al., “Monocyte chemoattractant protein 1 expression and proliferation in primary central nervous system lymphoma,” Oncology Letters, vol. 14, no. 1, pp. 264–270, 2017. View at Publisher · View at Google Scholar
  11. Q. Wei, X. Huang, B. Fu et al., “IMP3 expression in biopsy specimens of colorectal cancer predicts lymph node metastasis and TNM stage,” International Journal of Clinical & Experimental Pathology, vol. 8, no. 9, pp. 11024–11032, 2015. View at Google Scholar
  12. C. M. Croce, “Oncogenes and cancer,” The New England Journal of Medicine, vol. 358, no. 5, pp. 502–511, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. H. J. Weir, J. D. Lane, and N. Balthasar, “SIRT3: a central regulator of mitochondrial adaptation in health and disease,” Genes & Cancer, vol. 4, no. 3-4, pp. 118–124, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. L. W. Finley and M. C. Haigis, “Metabolic regulation by SIRT3: implications for tumorigenesis,” Trends in Molecular Medicine, vol. 18, no. 9, pp. 516–523, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Shulga and J. G. Pastorino, “Ethanol sensitizes mitochondria to the permeability transition by inhibiting deacetylation of cyclophilin-D mediated by sirtuin-3,” Journal of Cell Science, vol. 123, Part 23, pp. 4117–4127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. P. T. Schumacker, “SIRT3 controls cancer metabolic reprogramming by regulating ROS and HIF,” Cancer Cell, vol. 19, no. 3, pp. 299-300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Guarente, “Introduction: sirtuins in aging and diseases,” Methods in Molecular Biology, vol. 1077, pp. 3–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Zhao, H. Yang, X. Wang, R. Zhang, C. Wang, and Z. Guo, “Sirtuin-3 (SIRT3) expression is associated with overall survival in esophageal cancer,” Annals of Diagnostic Pathology, vol. 17, no. 6, pp. 483–485, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Liu, Z. Huang, H. Jiang, and F. Shi, “The sirtuin 3 expression profile is associated with pathological and clinical outcomes in colon cancer patients,” BioMed Research International, vol. 2014, Article ID 871263, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Y. Zhang and L. M. Zhou, “Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation,” Biochemical and Biophysical Research Communications, vol. 423, no. 1, pp. 26–31, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. J. George, M. Nihal, C. K. Singh, W. Zhong, X. Liu, and N. Ahmad, “Pro-proliferative function of mitochondrial Sirtuin deacetylase SIRT3 in human melanoma,” The Journal of Investigative Dermatology, vol. 136, no. 4, pp. 809–818, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Shackelford, S. Hirsh, K. Henry, A. Abdel-Mageed, E. Kandil, and D. Coppola, “Nicotinamide phosphoribosyltransferase and SIRT3 expression are increased in well-differentiated thyroid carcinomas,” Anticancer Research, vol. 33, no. 8, pp. 3047–3052, 2013. View at Google Scholar